Výsledky vyhledávání - "Chen, Roger S."

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Conference

Taiwanâ€™s Arms Procurement Policymaking in Transition: The Kidds Acquisition Controversy.

Autor: Chen, Roger S.¹ sjchen@ccit.edu.tw

Publikováno v: Conference Papers -- Midwestern Political Science Association. 2004 Annual Meeting, Chicago, IL, p1-28. 28p. 2 Diagrams.

Zobrazit plný text záznamu

Akademický článek

Chiral inversion of the second generation IMiD™ CC-4047 (ACTIMID™) in human plasma and phosphate-buffered saline.

Autor: Teo, Steve K., Chen, Yong, Muller, George W., Chen, Roger S., D. Thomas, Steve, Stirling, David I., Chandula, Reddy S.

Publikováno v: Chirality; 2003, Vol. 15 Issue 4, p348-351, 4p

Zobrazit plný text záznamu

Periodical

Immunomodulatory Drugs (IMiDs) Increase the Production of IL-2 from Stimulated T Cells by Increasing PKC-θ Activation and Enhancing the DNA-Binding Activity of AP-1 but Not NF-κB, OCT-1, or NF-AT

Autor: Payvandi, Faribourz, Wu, Lei, Naziruddin, Syedah D., Haley, Maura, Parton, Anastasia, Schafer, Peter H., Chen, Roger S., Muller, George W., Hughes, Christopher C.W., Stirling, David I.

Publikováno v: Journal of Interferon & Cytokine Research; October 2005, Vol. 25 Issue: 10 p604-616, 13p

Zobrazit plný text záznamu

Akademický článek

Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-α, IL-1β, and LPS-stimulated human PBMC in a partially IL-10-dependent manner

Autor: Payvandi, Faribourz fpayvandi@celgene.com, Wu, Lei¹, Haley, Maura¹, Schafer, Peter H.¹, Zhang, Ling-Hua¹, Chen, Roger S.¹, Muller, George W.¹, Stirling, David I.¹

Publikováno v: Cellular Immunology. Aug2004, Vol. 230 Issue 2, p81-88. 8p.

Zobrazit plný text záznamu

Akademický článek

The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.

Autor: Zhang LH; Division of Immunotherapeutics, Celgene Corp., 86 Morris Avenue, Summit, NJ 07901, USA. Lzhang@celgene.com, Wu L, Raymon HK, Chen RS, Corral L, Shirley MA, Narla RK, Gamez J, Muller GW, Stirling DI, Bartlett JB, Schafer PH, Payvandi F

Publikováno v: Cancer research [Cancer Res] 2006 Jan 15; Vol. 66 (2), pp. 951-9.

Zobrazit plný text záznamu

Akademický článek

Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT.

Autor: Payvandi F; Department of Immunotherapeutics, Celgene Corporation, Summit, NJ 07901, USA. fpayvandi@celgene.com, Wu L, Naziruddin SD, Haley M, Parton A, Schafer PH, Chen RS, Muller GW, Hughes CC, Stirling DI

Publikováno v: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research [J Interferon Cytokine Res] 2005 Oct; Vol. 25 (10), pp. 604-16.

Zobrazit plný text záznamu

Akademický článek

Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs.

Autor: Schafer PH; Celgene Corporation, 7 Powder Horn Dr., Warren, NJ 07059, USA. pschafer@celgene.com, Gandhi AK, Loveland MA, Chen RS, Man HW, Schnetkamp PP, Wolbring G, Govinda S, Corral LG, Payvandi F, Muller GW, Stirling DI

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2003 Jun; Vol. 305 (3), pp. 1222-32. Date of Electronic Publication: 2003 Mar 20.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání